CBAK ENERGY TECHNOLOGY INC (CBAT) Fundamental Analysis & Valuation

NASDAQ:CBAT • US14986C1027

1.015 USD
+0 (+0.5%)
Last: Mar 12, 2026, 03:53 PM

This CBAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

CBAT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 91 industry peers in the Electrical Equipment industry. CBAT may be in some trouble as it scores bad on both profitability and health. CBAT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. CBAT Profitability Analysis

1.1 Basic Checks

  • In the past year CBAT has reported negative net income.
  • In the past year CBAT had a positive cash flow from operations.
  • In multiple years CBAT reported negative net income over the last 5 years.
  • In multiple years CBAT reported negative operating cash flow during the last 5 years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

  • The Return On Assets of CBAT (-1.79%) is better than 62.64% of its industry peers.
  • CBAT's Return On Equity of -5.36% is fine compared to the rest of the industry. CBAT outperforms 63.74% of its industry peers.
Industry RankSector Rank
ROA -1.79%
ROE -5.36%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

  • In the last couple of years the Profit Margin of CBAT has declined.
  • Looking at the Gross Margin, with a value of 14.07%, CBAT is doing worse than 63.74% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CBAT has grown nicely.
  • CBAT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

2

2. CBAT Health Analysis

2.1 Basic Checks

  • CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CBAT has about the same amout of shares outstanding than it did 1 year ago.
  • CBAT has more shares outstanding than it did 5 years ago.
  • CBAT has a better debt/assets ratio than last year.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -0.14, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.14, CBAT is in line with its industry, outperforming 49.45% of the companies in the same industry.
  • CBAT has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.29, CBAT is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z -0.14
ROIC/WACCN/A
WACC5.92%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • CBAT has a Current Ratio of 0.69. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CBAT has a Current ratio of 0.69. This is amonst the worse of the industry: CBAT underperforms 83.52% of its industry peers.
  • CBAT has a Quick Ratio of 0.69. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.54, CBAT is doing worse than 79.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.54
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. CBAT Growth Analysis

3.1 Past

  • CBAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.18%.
  • The earnings per share for CBAT have been decreasing by -42.83% on average. This is quite bad
  • Looking at the last year, CBAT shows a very negative growth in Revenue. The Revenue has decreased by -22.02% in the last year.
  • CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.40% yearly.
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%

3.2 Future

  • Based on estimates for the next years, CBAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.42% on average per year.
  • CBAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.48% yearly.
EPS Next Y-139.23%
EPS Next 2Y-11.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.19%
Revenue Next 2Y30.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.05 -0.05 0.1 0.15

2

4. CBAT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CBAT. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 9.95, the valuation of CBAT can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, CBAT is valued cheaper than 92.31% of the companies in the same industry.
  • CBAT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.27.
Industry RankSector Rank
PE N/A
Fwd PE 9.95
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as CBAT's earnings are expected to decrease with -11.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.42%
EPS Next 3YN/A

0

5. CBAT Dividend Analysis

5.1 Amount

  • CBAT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CBAT Fundamentals: All Metrics, Ratios and Statistics

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (3/12/2026, 3:53:52 PM)

1.015

+0 (+0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-10
Earnings (Next)03-16
Inst Owners2.38%
Inst Owner Change-11.71%
Ins Owners5.58%
Ins Owner Change0%
Market Cap89.98M
Revenue(TTM)161.76M
Net Income(TTM)-6.51M
Analysts0
Price Target1.53 (50.74%)
Short Float %0.45%
Short Ratio1.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)26.47%
Max EPS beat(2)173.53%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)35.26%
Min Revenue beat(2)18.4%
Max Revenue beat(2)52.11%
Revenue beat(4)2
Avg Revenue beat(4)-3.55%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)52.11%
Revenue beat(8)2
Avg Revenue beat(8)-9.8%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.95
P/S 0.56
P/FCF N/A
P/OCF 3.16
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0.1
Fwd EY10.05%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.32
OCFY31.62%
SpS1.82
BVpS1.37
TBVpS1.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.79%
ROE -5.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.07%
FCFM N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 509.98%
Cap/Sales 22.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.54
Altman-Z -0.14
F-Score2
WACC5.92%
ROIC/WACCN/A
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-139.23%
EPS Next 2Y-11.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%
Revenue Next Year-0.19%
Revenue Next 2Y30.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-149.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.57%
OCF growth 3YN/A
OCF growth 5YN/A

CBAK ENERGY TECHNOLOGY INC / CBAT FAQ

What is the fundamental rating for CBAT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CBAT.


What is the valuation status of CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CBAK ENERGY TECHNOLOGY INC (CBAT). This can be considered as Overvalued.


How profitable is CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

CBAK ENERGY TECHNOLOGY INC (CBAT) has a profitability rating of 2 / 10.


Can you provide the financial health for CBAT stock?

The financial health rating of CBAK ENERGY TECHNOLOGY INC (CBAT) is 2 / 10.